Literature DB >> 28691327

Ending cervical cancer: A call to action.

Sanchia Aranda1, Seth Berkley2, Sally Cowal3, Mark Dybul4, Tim Evans5, Katja Iversen6, Matshidiso Moeti7, Babatunde Osotimehin8, Stefan Peterson9, Peter Piot10, Chittaranjan N Purandare11, Michel Sidibé12, Ted Trimble13, Vivien Davis Tsu14.   

Abstract

The outlook for elimination of the scourge of cervical cancer is bright, because we now have the tools to achieve this goal. In recent years human papillomavirus (HPV) vaccination in high-income countries has resulted in dramatic decreases in HPV infection and associated cervical disease. If all countries with a substantial burden of disease introduce the vaccine nationally, we can protect the vast majority of women and girls most at risk. For women who are beyond the vaccination target age, progress has been made in screening and treatment for cervical precancer, but we must accelerate this momentum to reduce incidence and mortality worldwide to the very low rates found in wealthier countries. Human and financial resources must be increased and directed to programs that follow best practices and reach all women, including the marginalized or disadvantaged. Seven key actions are recommended. Now is the time for action at national, regional, and global levels.
© 2017 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Cervical cancer; HPV vaccine; Low- and middle-income countries; Prevention; Screening

Mesh:

Substances:

Year:  2017        PMID: 28691327     DOI: 10.1002/ijgo.12182

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  11 in total

1.  Manifesto for global women's health.

Authors:  Ophira Ginsburg
Journal:  Nat Rev Clin Oncol       Date:  2017-09-12       Impact factor: 66.675

Review 2.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

3.  Impact of HIV on human papilloma virus-mediated cervical disease progression.

Authors:  Sten H Vermund; Karen F Kelley
Journal:  AIDS       Date:  2018-07-31       Impact factor: 4.177

4.  Reducing Poverty-Related Disparities in Cervical Cancer: The Role of HPV Vaccination.

Authors:  Jennifer C Spencer; Noel T Brewer; Tamera Coyne-Beasley; Justin G Trogdon; Morris Weinberger; Stephanie B Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-09-09       Impact factor: 4.254

5.  PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer.

Authors:  Hongfang Li; Gaogao Sun; Chang Liu; Jing Wang; Rong Jing; Jie Wang; Xiaohuan Zhao; Xiaoyan Xu; Yongxiu Yang
Journal:  Onco Targets Ther       Date:  2017-11-27       Impact factor: 4.147

6.  Cervical cancer in Ethiopia - predictors of advanced stage and prolonged time to diagnosis.

Authors:  Matthias Begoihn; Assefa Mathewos; Abreha Aynalem; Tigeneh Wondemagegnehu; Ulrike Moelle; Muluken Gizaw; Andreas Wienke; Christoph Thomssen; Dawit Worku; Adamu Addissie; Ahmedin Jemal; Eva Johanna Kantelhardt
Journal:  Infect Agent Cancer       Date:  2019-11-11       Impact factor: 2.965

7.  Ghanaian women's perception on cervical cancer threat, severity, and the screening benefits: A qualitative study at Shai Osudoku District, Ghana.

Authors:  Evans Appiah Osei; Mary Ani-Amponsah
Journal:  Public Health Pract (Oxf)       Date:  2022-05-16

8.  Identification of potential biomarkers in cervical cancer with combined public mRNA and miRNA expression microarray data analysis.

Authors:  Sizhe Wang; Xiaojin Chen
Journal:  Oncol Lett       Date:  2018-08-17       Impact factor: 2.967

Review 9.  Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives.

Authors:  May Abdel-Wahab; Surbhi Grover; Eduardo Hernan Zubizarreta; Jose Alfredo Polo Rubio
Journal:  Brachytherapy       Date:  2020-09-11       Impact factor: 2.362

10.  Mapping evidence on management of cervical cancer in sub-Saharan Africa: scoping review protocol.

Authors:  Petmore Zibako; Mbuzeleni Hlongwa; Nomsa Tsikai; Sarah Manyame; Themba G Ginindza
Journal:  Syst Rev       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.